Literature DB >> 2243322

Spontaneous lymphocyte proliferation in vitro characterizes both HTLV-I and HTLV-II infection.

H Prince, S Kleinman, M Doyle, H Lee, P Swanson.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2243322

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN： 0894-9255


× No keyword cloud information.
  6 in total

1.  Increased all-cause and cancer mortality in HTLV-II infection.

Authors:  Hope H Biswas; Zhanna Kaidarova; George Garratty; Joan W Gibble; Bruce H Newman; James W Smith; Alyssa Ziman; Joy L Fridey; Ronald A Sacher; Edward L Murphy
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

2.  Spontaneous cell proliferation is associated with poor sensitivity to glucocorticoids in patients infected with HTLV.

Authors:  R P Lopes; M Menna-Barreto; M E Bauer
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

3.  Phenotypic expression of integrin membrane receptors on spontaneously proliferating CD8 cells in human T-lymphotropic virus type II (HTLV-II)-infected individuals.

Authors:  R B Lal; D L Rudolph; T Rowe; T M Folks
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

4.  Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  M C F Nascimento; J Primo; A Bittencourt; I Siqueira; M de Fátima Oliveira; R Meyer; A Schriefer; S B Santos; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

5.  Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection.

Authors:  Melissa T Bartman; Zhanna Kaidarova; Dale Hirschkorn; Ronald A Sacher; Joy Fridey; George Garratty; Joan Gibble; James W Smith; Bruce Newman; Anthony E Yeo; Edward L Murphy
Journal:  Blood       Date:  2008-08-28       Impact factor: 22.113

6.  Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.

Authors:  Silvane Braga Santos; Aurélia Fonseca Porto; André Luiz Muniz; Amélia Ribeiro de Jesus; Elza Magalhães; Ailton Melo; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  BMC Infect Dis       Date:  2004-03-02       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.